Medtronic To Distribute Viz.ai’s System For Identifying Strokes
Executive Summary
Medtronic will distribute Viz.ai’s artificial intelligence system for detection and triage of large vessel occlusions in the US alongside Medtronic's Solitaire stent-retrievers for revascularization of occluded blood vessels in the brain.
You may also be interested in...
Digital Health Companies Happify Health, Viz.ai Secure New Funding
Happify Health raises $73m to expand digital mental health platform; Viz.ai secures $71m to extend software beyond stroke care coordination.
Device/Diagnostics Quarterly Dealmaking Statistics, Q4 2019
Device financing during 2019’s final quarter totaled $1.6bn, a substantial decrease from Q3’s $4.05bn. Merger and acquisition activity, almost doubled from the previous quarter reaching $6.1bn; Stryker’s 4.7bn takeover of Wright Medical was the only billion-dollar transaction. Financings by diagnostics/research players totaled $1.3bn (the lowest quarter of the year) and eight companies were acquired, five of which together were valued at $981m.
Stroke Decision-Support Software Gets US Approval
While US FDA works on a new guidance for clinical decision support software, the agency has OK'd the de novo application for Viz.AI Contact, a software tool to help detect early signs of strokes.